BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 33100194)

  • 21. Exosomal miR-103-3p from LPS-activated THP-1 macrophage contributes to the activation of hepatic stellate cells.
    Chen L; Yao X; Yao H; Ji Q; Ding G; Liu X
    FASEB J; 2020 Apr; 34(4):5178-5192. PubMed ID: 32061112
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of Liver Fibrosis-Related MicroRNAs in Human Primary Hepatic Stellate Cells Using High-Throughput Sequencing.
    Liu X; Ma H; Wu R; Wang H; Xu H; Li S; Wang G; Lv G; Niu J
    Genes (Basel); 2022 Nov; 13(12):. PubMed ID: 36553468
    [TBL] [Abstract][Full Text] [Related]  

  • 23. miR-140-3p Knockdown Suppresses Cell Proliferation and Fibrogenesis in Hepatic Stellate Cells via PTEN-Mediated AKT/mTOR Signaling.
    Wu SM; Li TH; Yun H; Ai HW; Zhang KH
    Yonsei Med J; 2019 Jun; 60(6):561-569. PubMed ID: 31124340
    [TBL] [Abstract][Full Text] [Related]  

  • 24. miRNA-130b-5p promotes hepatic stellate cell activation and the development of liver fibrosis by suppressing SIRT4 expression.
    Wang H; Wang Z; Wang Y; Li X; Yang W; Wei S; Shi C; Qiu J; Ni M; Rao J; Cheng F
    J Cell Mol Med; 2021 Aug; 25(15):7381-7394. PubMed ID: 34272822
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel Insights on Notch signaling pathways in liver fibrosis.
    Ni MM; Wang YR; Wu WW; Xia CC; Zhang YH; Xu J; Xu T; Li J
    Eur J Pharmacol; 2018 May; 826():66-74. PubMed ID: 29501868
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activation of Hepatic Stellate Cells is Inhibited by microRNA-378a-3p via Wnt10a.
    Yu F; Fan X; Chen B; Dong P; Zheng J
    Cell Physiol Biochem; 2016; 39(6):2409-2420. PubMed ID: 27832641
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Succinate induces hepatic fibrogenesis by promoting activation, proliferation, and migration, and inhibiting apoptosis of hepatic stellate cells.
    Park SY; Le CT; Sung KY; Choi DH; Cho EH
    Biochem Biophys Res Commun; 2018 Feb; 496(2):673-678. PubMed ID: 29366478
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long non-coding RNA-non-coding RNA activated by DNA damage inhibition suppresses hepatic stellate cell activation via microRNA-495-3p/sphingosine 1-phosphate receptor 3 axis.
    Zou L; Shi C; Wang D; Cheng J; Wang Q; Wang L; Yang G
    Bioengineered; 2022 Mar; 13(3):6150-6162. PubMed ID: 35200103
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MicroRNA-145 induces the senescence of activated hepatic stellate cells through the activation of p53 pathway by ZEB2.
    Yang J; Lu Y; Yang P; Chen Q; Wang Y; Ding Q; Xu T; Li X; Li C; Huang C; Meng X; Li J; Zhang L; Wang X
    J Cell Physiol; 2019 May; 234(5):7587-7599. PubMed ID: 30479019
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Epigenetically-Regulated microRNA-378a Targets TGF-β2 in TGF-β1-Treated Hepatic Stellate Cells.
    Yu F; Yang J; Huang K; Pan X; Chen B; Dong P; Zheng J
    Cell Physiol Biochem; 2016; 40(1-2):183-194. PubMed ID: 27855367
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Blockade of YAP alleviates hepatic fibrosis through accelerating apoptosis and reversion of activated hepatic stellate cells.
    Yu HX; Yao Y; Bu FT; Chen Y; Wu YT; Yang Y; Chen X; Zhu Y; Wang Q; Pan XY; Meng XM; Huang C; Li J
    Mol Immunol; 2019 Mar; 107():29-40. PubMed ID: 30639476
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatic fibrosis: It is time to go with hepatic stellate cell-specific therapeutic targets.
    Ezhilarasan D; Sokal E; Najimi M
    Hepatobiliary Pancreat Dis Int; 2018 Jun; 17(3):192-197. PubMed ID: 29709350
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synergistic antifibrotic effects of miR-451 with miR-185 partly by co-targeting EphB2 on hepatic stellate cells.
    Chen X; Zhang D; Wang Y; Chen K; Zhao L; Xu Y; Jiang H; Wang S
    Cell Death Dis; 2020 May; 11(5):402. PubMed ID: 32467578
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Histone H3K27 methyltransferase EZH2 and demethylase JMJD3 regulate hepatic stellate cells activation and liver fibrosis.
    Jiang Y; Xiang C; Zhong F; Zhang Y; Wang L; Zhao Y; Wang J; Ding C; Jin L; He F; Wang H
    Theranostics; 2021; 11(1):361-378. PubMed ID: 33391480
    [No Abstract]   [Full Text] [Related]  

  • 35. Regulatory Functions and Mechanisms of Circular RNAs in Hepatic Stellate Cell Activation and Liver Fibrosis.
    Nokkeaw A; Thamjamrassri P; Tangkijvanich P; Ariyachet C
    Cells; 2023 Jan; 12(3):. PubMed ID: 36766720
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MicroRNA-146a modulates TGF-beta1-induced hepatic stellate cell proliferation by targeting SMAD4.
    He Y; Huang C; Sun X; Long XR; Lv XW; Li J
    Cell Signal; 2012 Oct; 24(10):1923-30. PubMed ID: 22735812
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PU.1-deficient mice are resistant to thioacetamide-induced hepatic fibrosis: PU.1 finely regulates Sirt1 expression via transcriptional promotion of
    Liu Q; Zhang Y; Yang S; Wu Y; Wang J; Yu W; Liu Y
    Biosci Rep; 2017 Dec; 37(6):. PubMed ID: 29162670
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A new strategy for treatment of liver fibrosis: letting MicroRNAs do the job.
    Chen SL; Zheng MH; Shi KQ; Yang T; Chen YP
    BioDrugs; 2013 Feb; 27(1):25-34. PubMed ID: 23329398
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Huangqi Decoction, a compound Chinese herbal medicine, inhibits the proliferation and activation of hepatic stellate cells by regulating the long noncoding RNA-C18orf26-1/microRNA-663a/transforming growth factor-β axis.
    Dong BS; Liu FQ; Yang WN; Li XD; Shi MJ; Li MR; Yan XL; Zhang H
    J Integr Med; 2023 Jan; 21(1):47-61. PubMed ID: 36456413
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatic stellate cells role in the course of metabolic disorders development - A molecular overview.
    Bourebaba N; Marycz K
    Pharmacol Res; 2021 Aug; 170():105739. PubMed ID: 34171492
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.